HH pathway-related proteins have been shown to predict prognostic outcomes in advanced NSCLC patients, and overexpressions of SHH and Gli1 are strongly associated with poor prognostic outcomes. This evidence concerns the gene GLI1 and non-small cell lung carcinoma.